5-90706403-C-CTT
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP6_ModerateBS1
The NM_032119.4(ADGRV1):c.8730+20_8730+21dupTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00851 in 1,355,026 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00023 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0095 ( 0 hom. )
Consequence
ADGRV1
NM_032119.4 intron
NM_032119.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0450
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 5-90706403-C-CTT is Benign according to our data. Variant chr5-90706403-C-CTT is described in ClinVar as [Benign]. Clinvar id is 1165478.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4_exome allele frequency = 0.00951 (11493/1208528) while in subpopulation AFR AF= 0.0155 (385/24878). AF 95% confidence interval is 0.0142. There are 0 homozygotes in gnomad4_exome. There are 5571 alleles in male gnomad4_exome subpopulation. Median coverage is 25. This position pass quality control queck.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000225 AC: 33AN: 146426Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
33
AN:
146426
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00951 AC: 11493AN: 1208528Hom.: 0 Cov.: 25 AF XY: 0.00932 AC XY: 5571AN XY: 597936
GnomAD4 exome
AF:
AC:
11493
AN:
1208528
Hom.:
Cov.:
25
AF XY:
AC XY:
5571
AN XY:
597936
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000225 AC: 33AN: 146498Hom.: 0 Cov.: 0 AF XY: 0.000267 AC XY: 19AN XY: 71250
GnomAD4 genome
AF:
AC:
33
AN:
146498
Hom.:
Cov.:
0
AF XY:
AC XY:
19
AN XY:
71250
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 12, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at